David Jeffs insider trades: Cell MedX (CMXC) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 29, 2023 | CMXC | ↑ Buy | 7,500,000 | $0.01 | $53K | Son | Jan 10, 2024 (12d) |
| Dec 29, 2023 | CMXC | ↑ Buy | 7,500,000 | $0.01 | $53K | Daughter | Jan 10, 2024 (12d) |
| Jan 14, 2011 | LIVC | ↑ Buy | 140,000 | $0.09 | $12K | Direct | Jan 14, 2011 (0d) |
| May 25, 2007 | CMNN | ↑ Buy | 30,100 | $0.98 | $29K | Direct | May 31, 2007 (6d) |
| Mar 21, 2007 | CMNN | ↑ Buy | 10,000 | $0.91 | $9K | Direct | Mar 22, 2007 (1d) |
| Mar 16, 2007 | CMNN | ↑ Buy | 10,000 | $0.88 | $9K | Direct | Mar 21, 2007 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David Jeffs's insider trades
David Jeffs is Chief Executive Officer at Cell MedX (CMXC). Since Mar 16, 2007, David has reported 6 open-market purchases worth $164K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (3 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CMXC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.